Suppr超能文献

血小板的黏附受到VCL的抑制,VCL是血管性血友病因子的重组片段(从亮氨酸504到赖氨酸728)。

Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.

作者信息

Sixma J J, Ijsseldijk M J, Hindriks G, van Zanten G H, Gorecki M, Panet A, Garfinkel L I, de Groot P G

机构信息

Department of Haematology, University Hospital Utrecht, Netherlands.

出版信息

Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):64-71. doi: 10.1161/01.atv.16.1.64.

Abstract

VCL, fragment Leu504 to Lys728 of von Willebrand factor (vWF) expressed in Escherichia coli, contains the glycoprotein (GP) Ib-binding domain of vWF. This fragment inhibited ristocetin-induced platelet aggregation with an IC50 of 0.2 mumol/L and botrocetin-induced platelet aggregation with an IC50 of 0.08 mumol/L. We studied the antiadhesive profile of VCL by adding it to blood that was circulated over various adhesive surfaces. VCL inhibited adhesion to endothelial cell matrix, which served as a model of the vessel wall. Maximal inhibition at a high shear rate of 1600 s-1 was stronger (60%) than at a low shear rate of 300 s-1 (40%). Half maximal inhibition was found to be 1.5 mumol/L at both shear rates. The role of various adhesive molecules was investigated in more detail by coating glass coverslips with collagen type I, laminin, fibronectin, or vWF. Fibrinogen was studied as well. Platelet adhesion to laminin and vWF was not inhibited by VCL. Adhesion to collagen, fibronectin, and fibrinogen was particularly inhibited at a high shear rate. VCL coated to a coverslip caused a concentration-dependent adhesion that was blocked by antibodies against GPIb, which block interaction with vWF. Binding studies showed a nonsaturable ristocetin binding of VCL to platelets that was blocked by vWF or inhibitory antibodies against GPIb. Binding to collagen was weak, and VCL did not inhibit binding of vWF at a 5000-fold excess. From these data, we conclude that VCL inhibits adhesion in all cases in which adhesion is vWF dependent by competing for vWF binding to activated GPIb. The lack of inhibition of adhesion to vWF as a single molecule may be explained by assuming that this adhesion is determined by interaction of nonactivated GPIb with vWF that has been changed in conformation by adsorption. Studies investigating thrombus formation on the connective tissue of an atherosclerotic plaque in a human coronary artery showed that VCL was able to partially prevent this thrombus formation. VCL may be of value in preventing adhesion and thrombus formation under conditions in which these processes are dependent on vWF.

摘要

VCL是在大肠杆菌中表达的血管性血友病因子(vWF)的Leu504至Lys728片段,包含vWF的糖蛋白(GP)Ib结合结构域。该片段抑制瑞斯托霉素诱导的血小板聚集,IC50为0.2 μmol/L,抑制蛇毒凝血酶诱导的血小板聚集,IC50为0.08 μmol/L。我们通过将VCL添加到在各种粘附表面循环的血液中来研究其抗粘附特性。VCL抑制对内皮细胞基质的粘附,内皮细胞基质可作为血管壁的模型。在1600 s-1的高剪切速率下的最大抑制作用(60%)比在300 s-1的低剪切速率下(40%)更强。在两种剪切速率下,半数最大抑制浓度均为1.5 μmol/L。通过用I型胶原、层粘连蛋白、纤连蛋白或vWF包被玻璃盖玻片,更详细地研究了各种粘附分子的作用。还研究了纤维蛋白原。VCL不抑制血小板对层粘连蛋白和vWF的粘附。在高剪切速率下,对胶原、纤连蛋白和纤维蛋白原的粘附受到特别抑制。包被在盖玻片上的VCL引起浓度依赖性粘附,该粘附被抗GPIb抗体阻断,抗GPIb抗体可阻断与vWF的相互作用。结合研究表明,VCL与血小板的瑞斯托霉素结合不具有饱和性,可被vWF或抗GPIb抑制性抗体阻断。与胶原的结合较弱,并且在vWF过量5000倍时,VCL不抑制vWF的结合。根据这些数据,我们得出结论,VCL通过竞争vWF与活化的GPIb的结合,在所有vWF依赖性粘附的情况下均抑制粘附。作为单一分子时对vWF粘附缺乏抑制作用,可能是因为这种粘附是由未活化的GPIb与因吸附而构象改变的vWF之间的相互作用所决定的。对人类冠状动脉粥样硬化斑块结缔组织上血栓形成的研究表明,VCL能够部分预防这种血栓形成。在这些过程依赖于vWF的情况下,VCL在预防粘附和血栓形成方面可能具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验